Skip to main content
SpringerLink
Log in

Protein Binding Drug Displacement Interactions

Fact or Fiction?

  • Leading Article
  • Published:
Clinical Pharmacokinetics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Aarons LJ, Rowland M. Kinetics of drug displacement interactions. Journal of Pharmacokinetics and Biopharmaceutics 9: 181–190, 1981

    PubMed  CAS  Google Scholar 

  • Abbott FS, Kassam J, Orr JM, Farrell K. The effect of aspirin on valproic acid metabolism. Clinical Pharmacology and Therapeutics 40: 94–100, 1986

    Article  PubMed  CAS  Google Scholar 

  • Baciewicz AM. Carbamazepine drug interactions. Therapeutic Drug Monitoring 8: 305–317, 1986

    Article  PubMed  CAS  Google Scholar 

  • Bjornsson TD, Meffin PJ, Blaschke TF. Interaction of Clofibrate with warfarin. I. Effect of Clofibrate on the disposition of the optical enantiomorphs of warfarin. Journal of Pharmacokinetics and Biopharmaceutics 5: 495–505, 1977

    PubMed  CAS  Google Scholar 

  • Bjornsson TD, Meffin PJ, Swezey S, Blaschke TF. Clofibrate displaces warfarin from plasma proteins in man: an example of a pure displacement interaction. Journal of Pharmacology and Experimental Therapeutics 210: 316–321, 1979

    PubMed  CAS  Google Scholar 

  • Boston Collaborative Drug Surveillance Program. Interaction between chloral hydrate and warfarin. New England Journal of Medicine 286: 53–55, 1982

    Google Scholar 

  • Bourke RS, Cheda G, Bremer A, Watanabe O, Tower DB. Inhibition of renal tubular transport of methotrexate by probenecid. Cancer Research 35: 110–116, 1975

    PubMed  CAS  Google Scholar 

  • Brown JE, Kitchell BB, Bjornsson TD, Shand DG. The artifactual nature of heparin-induced drug protein binding alterations. Clinical Pharmacology and Therapeutics 30: 636–643, 1981

    Article  PubMed  CAS  Google Scholar 

  • Bruni J, Gallo JM, Lee CS, Perchalski RJ, Wilder BJ. Interactions of valproic acid with phenytoin. Neurology 30: 1233–1236, 1980

    Article  PubMed  CAS  Google Scholar 

  • Chou RC, Levy G. Effect of heparin or salicylate infusion on serum protein binding and on concentrations of phenytoin in serum, brain and cerebrospinal fluid of rats. Journal of Pharmacology and Experimental Therapeutics 219: 42–48, 1981

    PubMed  CAS  Google Scholar 

  • Christensen LK, Hansen JM, Kristensen M. Sulphaphenazole-induced hypoglycaemic attacks in tolbutamide-treated diabetics. Lancet 2: 1298–1301, 1963

    Article  PubMed  CAS  Google Scholar 

  • D’Arcy PF, McElnay JC. Drug interactions involving the displacement of drugs from plasma protein and tissue binding sites. Pharmacology and Therapeutics 17: 211–220, 1982

    Article  PubMed  Google Scholar 

  • Dhillon S, Richens A. Valproic acid and diazepam interaction in vivo. British Journal of Clinical Pharmacology 13: 553–560, 1982

    Article  PubMed  CAS  Google Scholar 

  • Evans WE, Christensen ML. Drug interactions with methotrexate. Journal of Rheumatology 12 (Suppl. 12): 15–20, 1985

    PubMed  CAS  Google Scholar 

  • Fraser DG, Ludden TM, Evens RP, Sutherland EW. Displacement of phenytoin from plasma binding sites by salicylate. Clinical Pharmacology and Therapeutics 27: 165–169, 1980

    Article  PubMed  CAS  Google Scholar 

  • Giacomini KM, Giacomini JC, Blaschke TF. Absence of effect of heparin on the binding of prazosin and phenytoin to plasma proteins. Biochemical Pharmacology 29: 3337–3340, 1980a

    Article  PubMed  CAS  Google Scholar 

  • Giacomini KM, Swezey SE, Giacomini JC, Blaschke TF. Administration of heparin causes in vitro release of non-esterified fatty acids in human plasma. Life Sciences 27: 771–780, 1980b

    Article  PubMed  CAS  Google Scholar 

  • Gillette JR. Overview of drug-protein binding. Annals of the New York Academy of Sciences 226: 6–17, 1973

    Article  PubMed  CAS  Google Scholar 

  • Griner PF, Raisz LG, Rickles FR, Wiesner PJ, Odoroff CL. Chloral hydrate and warfarin interaction: clinical significance? Annals of Internal Medicine 74: 540–543, 1971

    PubMed  CAS  Google Scholar 

  • Hartrick CT, Dirkes WE, Coyle DE, Raj PR, Denson DD. Influence of bupivacaine on mepivacaine protein binding. Clinical Pharmacology and Therapeutics 36: 546–550, 1984

    Article  PubMed  CAS  Google Scholar 

  • Kates RE, Tozer TN, Sorby DL. Increased methotrexate toxicity due to concurrent probenecid administration. Biochemical Pharmacology 25: 1485–1488, 1976

    Article  PubMed  CAS  Google Scholar 

  • Knott C, Hamshaw-Thomas A, Reynolds F. Phenytoin-valproate interaction: importance of saliva monitoring in epilepsy. British Medical Journal 284: 13–16, 1982

    Article  PubMed  CAS  Google Scholar 

  • Koch-Weser J, Seller EM. Binding of drugs to serum albumin (Part II). New England Journal of Medicine 294: 526–531, 1976

    Article  PubMed  CAS  Google Scholar 

  • Kornhauser DM, Wood AJJ, Vestal RE, Wilkinson GR, Branch RA, et al. Biological determinants of propranolol disposition in man. Clinical Pharmacology and Therapeutics 23: 165–174, 1978

    PubMed  CAS  Google Scholar 

  • Kristensen MB. Drug interactions and clinical pharmacokinetics. Clinical Pharmacokinetics 1: 351–372, 1976

    Article  PubMed  CAS  Google Scholar 

  • Kunin CM. Clinical pharmacology of the new penicillins. II. Effect of drugs which interfere with binding to serum proteins. Clinical Pharmacology and Therapeutics 7: 180–188, 1966

    PubMed  CAS  Google Scholar 

  • Leonard RF, Knott PJ, Rankin GD, Robinson DS, Melnick DE. Phenytoin-salicylate interaction. Clinical Pharmacology and Therapeutics 29: 56–60, 1981

    Article  PubMed  CAS  Google Scholar 

  • Lewis RJ, Trager WF, Chan KK, Breckenridge A, Orme M, et al. Warfarin: stereochemical aspects of its metabolism and the interactions with phenylbutazone. Journal of Clinical Investigation 53: 1607–1617, 1974

    Article  PubMed  CAS  Google Scholar 

  • Liegler DG, Henderson ES, Hahn MA, Oliverio VT. The effect of organic acids on renal clearance of methotrexate in man. Clinical Pharmacology and Therapeutics 10: 849–857, 1969

    PubMed  CAS  Google Scholar 

  • Lima JJ, Boudoulas H, Blanford MF. Concentration dependence of disopyramide binding to serum protein and its influence on kinetics and dynamics. Journal of Pharmacology and Experimental Therapeutics 219: 741–747, 1981

    PubMed  CAS  Google Scholar 

  • Lohman JJJM, Hooymans PM, Koten MLP, Verhey MTJM, Merkus FWHM. Effect of heparin on digitoxin protein binding. Clinical Pharmacology and Therapeutics 37: 55–60, 1985

    Article  PubMed  CAS  Google Scholar 

  • MacKichan JJ. Pharmacokinetic consequences of drug displacement from blood and tissue proteins. Clinical Pharmacokinetics 9 (Suppl. 1): 32–41, 1984

    Article  PubMed  CAS  Google Scholar 

  • MacKichan JJ, Zola EM. Determinants of carbamazepine and carbamazepine 10,11-epoxide binding to serum protein, albumin and alpha-1-acid glycoprotein. British Journal of Clinical Pharmacology 18: 487–493, 1984

    Article  PubMed  CAS  Google Scholar 

  • MacPhee GJA, Mitchell JR, Wiseman L, McLellan AR, Park BK, et al. Effect of sodium valproate on carbamazepine disposition and psychomotor profile in man. British Journal of Clinical Pharmacology 25: 59–66, 1988

    Article  PubMed  CAS  Google Scholar 

  • Mattson RH, Cramer JA, Williamson PD, Novelly RA. Valproic acid in epilepsy: clinical and pharmacological effects. Annals of Neurology 3: 20–25, 1978

    Article  PubMed  CAS  Google Scholar 

  • McElnay JC, D’Arcy PF. Protein binding displacement interactions and their clinical importance. Drugs 25: 495–513, 1983

    Article  PubMed  CAS  Google Scholar 

  • McQueen EG, Wardell WM. Drug displacement from protein binding isolation of a redistributional drug interaction in vivo. British Journal of Pharmacology 43: 312–324, 1971

    PubMed  CAS  Google Scholar 

  • Neuvonen PJ, Lehtovaara R, Bardy A, Elomaa E. Antipyretic analgesics in patients on antiepileptic drug therapy. European Journal of Clinical Pharmacology 15: 263–268, 1979

    Article  PubMed  CAS  Google Scholar 

  • Oie S, Levy G. Effect of sulfisoxazole on pharmacokinetics of free and plasma protein-bound bilirubin in experimental unconjugated hyperbilirubinemia. Journal of Pharmaceutical Sciences 68: 6–9, 1979

    Article  PubMed  CAS  Google Scholar 

  • Olanow CW, Finn AL, Prussak C. The effects of salicylate on the pharmacokinetics of phenytoin. Neurology 31: 341–342, 1981

    Article  PubMed  CAS  Google Scholar 

  • O’Reilly RA, Trager WF, Motley CH. Stereoselective interaction of phenylbutazone with (12C/13C)warfarin pseudoracemates in man. Journal of Clinical Investigation 65: 746–753, 1980

    Article  PubMed  Google Scholar 

  • Orr JM, Abbott FS, Farrell K, Ferguson S, Sheppard I, et al. Interaction between valproic acid and aspirin in epileptic children: serum protein binding and metabolic effects. Clinical Pharmacology and Therapeutics 31: 642–649, 1982

    Article  PubMed  CAS  Google Scholar 

  • Paxton JW. Effects of aspirin on salivary and serum phenytoin kinetics in healthy subjects. Clinical Pharmacology and Therapeutics 27: 170–178, 1980

    Article  PubMed  CAS  Google Scholar 

  • Paxton JW. Interaction of probenecid with the protein binding of methotrexate. Pharmacology 28: 86–89, 1984

    Article  PubMed  CAS  Google Scholar 

  • Perucca E, Hebdige S, Frigo GM, Gatti G, Lecchini S, et al. Interaction between phenytoin and valproic acid: plasma protein binding and metabolic effects. Clinical Pharmacology and Therapeutics 28: 779–789, 1980

    Article  PubMed  CAS  Google Scholar 

  • Rodin EA, DeSousa G, Haidukewych D, Lodhi R, Berchou RC. Dissociation between free and bound phenytoin levels in presence of valproate sodium. Archives of Neurology 38: 240–242, 1981

    Article  PubMed  CAS  Google Scholar 

  • Rowland M, Matin SB. Kinetics of drug-drug interactions. Journal of Pharmacokinetics and Biopharmaceutics 1: 553–567, 1973

    CAS  Google Scholar 

  • Sellers EM. Plasma protein displacement interactions are rarely of clinical significance. Pharmacology 18: 225–227, 1979

    Article  PubMed  CAS  Google Scholar 

  • Sellers EM. Drug displacement interactions: a case study of the phenylbutazone-warfarin interaction. In Reidenberg (Ed.) Drug protein binding, pp. 257–273, Praeger Publishers, New York, 1984

    Google Scholar 

  • Sellers EM, Koch-Weser J. Potentiation of warfarin-induced hypoprothrombinemia by chloral hydrate. New England Journal of Medicine 283: 827–831, 1970

    Article  PubMed  CAS  Google Scholar 

  • Sellers EM, Koch-Weser J. Kinetics and clinical importance of displacement of warfarin from albumin by acidic drugs. Annals of the New York Academy of Sciences 179: 213–224, 1977

    Article  Google Scholar 

  • Sellers EM, Lang M, Koch-Weser J, Colman RW. Enhancement of warfarin-induced hypoprothrombinemia by triclofos. Clinical Pharmacology and Therapeutics 13: 911–915, 1972

    PubMed  CAS  Google Scholar 

  • Serlin MJ, Mossman S, Sibeon RG, Tempero KF, Breckenridge AM. Interaction between diflunisal and warfarin. Clinical Pharmacology and Therapeutics 28: 493–498, 1980

    Article  PubMed  CAS  Google Scholar 

  • Shand DG, Mitchell JR, Oates JA. Pharmacokinetic drug interactions. In Gillette et al. (Eds) Handbook of experimental pharmacology: concepts in biochemical pharmacology, Vol. 28/3, pp. 272–314, Springer-Verlag, New York, 1975

    Chapter  Google Scholar 

  • Stoeckel K, Trueb V, Buback UC, McNamara PJ. Effect of probenecid on the elimination and protein binding of ceftriaxone. European Journal of Clinical Pharmacology 34: 151–156, 1988

    Article  PubMed  CAS  Google Scholar 

  • Svensson CK, Woodruff MN, Lalka D. Influence of protein binding and use of unbound (free) drug concentrations. In Evans et al. (Eds) Applied pharmacokinetics, 2nd ed., pp. 187–219, Applied Therapeutics Inc., Spokane, WA, 1986

    Google Scholar 

  • Sweeney KR, Chapron DJ, Brandt L, Gomolin IH, Feig PU, et al. Toxic interaction between acetazolamide and salicylate: case reports and a pharmacokinetic explanation. Clinical Pharmacology and Therapeutics 40: 518–524, 1986

    Article  PubMed  CAS  Google Scholar 

  • Tsanaclis LM, Allen J, Perucca E, Routledge PA, Richens A. Effect of valproate on free plasma phenytoin concentrations. British Journal of Clinical Pharmacology 18: 17–20, 1984

    Article  PubMed  CAS  Google Scholar 

  • Udall JA. Warfarin-chloral hydrate interaction. Pharmacological activity and clinical significance. Annals of Internal Medicine 81: 341–344, 1974

    CAS  Google Scholar 

  • Udall JA. Clinical implications of warfarin interactions with five sedatives. American Journal of Cardiology 35: 67–71, 1975

    Article  PubMed  CAS  Google Scholar 

  • Upton RA, Williams RL, Buskin JN, Jones RM. Effects of probenecid on ketoprofen kinetics. Clinical Pharmacology and Therapeutics 31: 705–712, 1982

    Article  PubMed  CAS  Google Scholar 

  • Wesseling H, Mols-Thurkow I. Interaction of diphenylhydantoin (DPH) and tolbutamide in man. European Journal of Clinical Pharmacology 8: 75–78, 1975

    Article  PubMed  CAS  Google Scholar 

  • Yacobi A, Udall JA, Levy G. Serum protein binding as a determinant of warfarin body clearance and anticoagulant effect. Clinical Pharmacology and Therapeutics 19: 552–558, 1975

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. College of Pharmacy, The Ohio State University, 217 Parks Hall, 500 West 12th Avenue, Columbus, Ohio, 43210, USA

    Janis J. MacKichan

Authors
  1. Janis J. MacKichan
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

MacKichan, J.J. Protein Binding Drug Displacement Interactions. Clin-Pharmacokinet 16, 65–73 (1989). https://doi.org/10.2165/00003088-198916020-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003088-198916020-00001

Keywords

Search

Navigation